Botulinum neurotoxin in cervical dystonia revisited — Recent advances and unanswered questions

12Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Cervical dystonia (CD) usually presents a complex pattern of head/neck movements accompanied by tremor, myoclonic jerks and a wide spectrum of non-motor disturbances such as pain, depression, anxiety, and sleep problems. This is the most challenging indication for botulinum neurotoxin (BoNT) treatment. It can offer significant improvement, but it can be difficult after the first injection. Thorough examination and identification of the proper CD pattern, the identification of the muscles responsible, and adjusting doses given precisely under ultrasound and/or electromyographic guidance seem to be the key success modifiers. Nevertheless, this is a lifelong treatment and should be planned and conducted carefully to avoid failures and drop outs. The aim of this paper was to examine the current concepts in terms of anatomy, physiology and CD patterns (Col-Cap concept) as well as the proper dosages and any possible obstacles impeding successful treatment.

Cite

CITATION STYLE

APA

Sławek, J., & Jost, W. H. (2021). Botulinum neurotoxin in cervical dystonia revisited — Recent advances and unanswered questions. Neurologia i Neurochirurgia Polska. Via Medica. https://doi.org/10.5603/PJNNS.A2021.0029

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free